发明名称 |
Fused aminodihydrothiazine derivatives |
摘要 |
A compound represented by the general formula:;
or a pharmaceutically acceptable salt thereof or a solvate thereof, wherein Ring A is a C6-14 aryl group or the like, L is —NReCO— or the like (wherein Re is a hydrogen atom or the like), Ring B is a C6-14 aryl group or the like, X is a C1-3 alkylene group or the like, Y is a single bond or the like, Z is a C1-3 alkylene group or the like, R1 and R2 are each independently a hydrogen atom or the like, and R3, R4, R5 and R6 are independently a hydrogen atom, a halogen atom or the like, has an Aβ production inhibitory effect or a BACE1 inhibitory effect and is useful as a prophylactic or therapeutic agent for a neurodegenerative disease caused by Aβ and typified by Alzheimer-type dementia. |
申请公布号 |
US8946211(B2) |
申请公布日期 |
2015.02.03 |
申请号 |
US201313804691 |
申请日期 |
2013.03.14 |
申请人 |
Eisai R&D Management Co., Ltd. |
发明人 |
Suzuki Yuichi;Motoki Takafumi;Kaneko Toshihiko;Takaishi Mamoru;Ishida Tasuku;Kita Yoichi;Takeda Kunitoshi;Yamamoto Noboru;Khan Afzal;Dimopoulos Paschalis |
分类号 |
C07D513/02;A61K31/542 |
主分类号 |
C07D513/02 |
代理机构 |
Fish & Richardson P.C. |
代理人 |
Fish & Richardson P.C. |
主权项 |
1. A compound represented by the formula:or a pharmaceutically acceptable salt thereof, wherein:
R3 and R4 are independently selected from the group consisting of H and C1-6 alkyl, wherein the C1-6 alky is optionally substituted by 1, 2, or 3 substituents; R7a, R7b, and R7C are independently selected from the group consisting of H and X; R8a, R8b, and R8C are independently selected from the group consisting of H, X, CHmXn, and OCHmXn; wherein m is 0, 1, or 2; n is 1, 2, or 3; and X is halogen selected from the group consisting of fluorine, chlorine, bromine and iodine. |
地址 |
Tokyo JP |